SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-020768
Filing Date
2021-11-18
Accepted
2021-11-18 16:37:43
Documents
2
Period of Report
2021-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1699
2 poa_martell.htm EX-24 8638
  Complete submission text file 0001567619-21-020768.txt   11742
Mailing Address C/O KURA ONCOLOGY, INC. 3033 SCIENCE PARK RD, SUITE 220 SAN DIEGO CA 92121
Business Address
Martell Bridget A (Reporting) CIK: 0001629627 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39617 | Film No.: 211424926

Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Issuer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)